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 Introduction 
Nutritional metabolism in ruminants is tightly associated with productive traits, 
for example, milk production in dairy cows and meat production in beef cattle. Thus, 
the synthesis of milk is based on the influx of nutrients such as glucose, lipids, and 
amino acids. Likewise, the development of marbling in muscle largely is dependent 
on both lipid and protein metabolism. The liver is essential to these production 
processes, and also plays a role in the control of metabolism in peripheral tissues, 
including muscle and adipose tissues, in an endocrine manner (Iroz et al., 2015). 
Recent endocrinological studies have identified various hormone-like endocrine 
factors from peripheral tissues and organs other than endocrine glands. These 
hormone-like endocrine factors are referred to as peptide hormones and cytokines. 
The discovery of these endocrine factors has undermined the long-standing model in 
which metabolism in peripheral tissues, such as the liver, adipose tissue, and skeletal 
muscle, is controlled by the secretion of hormones from the endocrine glands, and 
led to the development of a new model in which various tissues secrete a range of 
hormone-like factors depending on their metabolic state, which results in the 
construction of a regulatory axis to maintain homeostasis in the whole body (Ouchi 
et al., 2011; Pedersen and Febbraio, 2012).  
Endocrine factors secreted from the liver are called hepatokines and mainly 
function to control glucose and lipid metabolism (Stefan and Häring, 2013). To date, 
a range of hepatokines have been identified: IGF-1, a well-known hormone derived 
from the liver with growth factor-like effects, is now considered a hepatokine (Musso 
et al., 2015); fetuin-A; fibroblast growth factor 21 (FGF21); selenoprotein-P (SeP); 
and angiopoietin-like proteins (ANGPTLs). These hepatokines have regulatory 
 effects on insulin sensitivity, glucose metabolism, and lipid metabolism (Stefan and 
Häring, 2013). Thus, increased understanding of hepatic endocrine function will 
provide new insights into the regulatory pathways of nutritional metabolism. This is 
particularly the case as the liver plays a pivotal role by sending out signals that 
reflect its metabolic state, such as elevated insulin resistance or accumulation of 
excess lipid under high dietary energy intake. 
The present study focuses on two novel hepatokines namely, angiopoietin-like 
protein 8 (ANGPTL8) and chemerin. ANGPTL8 is predominantly expressed in and 
secreted from the liver and adipose tissues in humans and mice (Quagliarini et al., 
2012). The most important physiological consequence of ANGPTL8 expression and 
secretion is the regulation of lipid metabolism, especially the control of blood fatty 
acid and triglyceride levels (Wang et al., 2013). The behaviors of chemerin and 
ANGPTL8 in humans and rodents suggest that these hepatokines also regulate 
glucose and lipid metabolism in ruminants and consequently have significant roles in 
productive traits. Chemerin is a secreted chemoattractant protein, which is highly 
expressed in the liver and adipose tissues of humans and rodents (Wittamer et al., 
2003; Roh et al., 2007; Takahashi et al., 2011). This chemokine is also reported to 
have physiological effects especially on glucose metabolism, such as insulin 
secretion, peripheral insulin sensitivity, and glucose uptake (Sell et al., 2009; 
Takahashi et al., 2011; Wargent et al., 2015). These physiological effects are 
considered to be mainly mediated by the chemerin receptor, chemokine-like receptor 
1 (CMKLR1), although chemerin has other receptors, namely C-C chemokine 
receptor-like 2 (CCRL2) and G protein-coupled receptor 1 (GPR1) (Rourke et al., 
2013). Currently, however, there is little precise information on the expression and 
 physiological function of these hepatokines in ruminants. Here, growing calves and 
dairy cows were used as animal models as their nutritional metabolism is 
dramatically but accurately controlled during weaning, growth, pregnancy and 
lactation. The aims of this study were: 
 
1. To investigate expression of ANGPTL8 in weaning calves and growing cattle; 
2. To investigate expression of ANGPTL8 in lactating/ dry-off dairy cows and 
periparturient cows. 
3. To investigate expression of chemerin and its receptors in weaning calves and 
growing cattle; 
4. To investigate expression of chemerin and its receptors in lactating/ dry-off dairy 
cows and periparturient cows; 
  
 Results and discussions 
Chapter 1. Expression of ANGPTL8 in weaning calves and growing cattle 
We examined the expressional levels of ANGPTL8 in (1) pre-weaning and 
post-weaning calves, and (2) growing and fattening cattle, to elucidate its role in the 
regulation of lipid metabolism in young calves. ANGPTL8 mRNA expression was 
observed in the liver and adipose tissues of Holstein calves. ANGPTL8 protein was 
detected in the liver and plasma, and found to localize at the cytosol of hepatocytes 
of Japanese Black calves, which indicate ANGPTL8 is a hepatokine secreted from 
liver in cattle. The expressional level of ANGPTL8 in the liver increased in 
post-weaning Japanese Black calves, whereas plasma ANGPTL8 protein level had 
tendency to increase in the same calves. Plasma level of phospholipid had tendency 
to decrease, and plasma acetoacetate level decreased in post-weaning calves. 
Meanwhile, the expressional levels of lipoprotein lipase (LPL) decreased in perirenal 
adipose tissue of post-weaning calves, compared to pre-weaning calves. Wang et al. 
reported a potential inhibitory function of ANGPTL8 on LPL (Wang et al., 2013). 
The data indicates that the upregulation of ANGPTL8 expression was a physiological 
adaptation to weaning in which plasma phospholipid declined because of the 
deprivation of dietary lipid intake, resulting in inhibition of peripheral LPL activity 
to decrease the uptake of lipid into tissues in such a low energy state caused by 
weaning. 
Next, we examined the expressional alteration of ANGPTL8 in weaned growing 
cattle. In growing Japanese Black cattle, the expressional level of ANGPTL8 in the 
liver peaked at 17 months of age, whereas there were no significant differences in its 
expressional level between the groups fed hay or concentrates throughout the 
 experimental period. Hepatic GPAT1 expressional level also peaked at 17 months of 
age, although expressional levels of FAS and LDLR were not controlled by feeding 
and age. Thus, the elevated expression of ANGPTL8 observed in calves at 17 months 
of age might contribute to the inhibition of lipid uptake in skeletal muscle and result 
in facilitating skeletal muscle growth. The results from weaning calves and growing 
cattle indicate that hepatic ANGPTL8 expression is controlled dynamically by 
physiological transition such as weaning and growth. 
 
Chapter 2. Expression of ANGPTL8 in lactating/ dry-off dairy cows and 
periparturient cows. 
The mobilization of fatty acids from adipose tissues and triglycerides from liver to 
the mammary gland plays an essential pathway providing lipids for lactogenesis. 
Lipid metabolism in dairy cows is controlled by metabolic hormones such as insulin 
and growth hormone. Due to its function in controlling blood lipid levels, ANGPTL8 
is suggested to regulate lactogenic metabolism in dairy cows. Here, we examined the 
pattern of expression of ANGPTL8 in these cattle. 
The level of hepatic ANGPTL8 mRNA was dramatically reduced on the day of 
parturition and at 1 week after parturition but returned to the levels seen at 
preparturition after 4 weeks. Plasma level of ANGPTL8 slightly decreased at the day 
of parturition and returned to original level in 1 week postpartum. The level of 
plasma triglycerides was lower on the day of parturition and at 1 week after 
parturition, whereas plasma NEFA levels were elevated at the same periods.  Plasma 
insulin level decreased in postpartum period. Treatment of cultured bovine 
hepatocytes with insulin revealed this hormone downregulates ANGPTL8 mRNA, 
 indicating insulin controls peripartum ANGPTL8 expression in liver of cows. 
Furthermore, changes in Hepatic ANGPTL8 mRNA and plasma triglycerides showed 
similar patterns of change during the periparturient period, suggesting that 
downregulation of ANGPTL8 contributed to the elevation of lipid uptake into the 
mammary gland, which facilitated the synthesis of milk lipids. 
 
Chapter 3. Expression of chemerin and its receptors in weaning calves and growing 
cattle 
First, we investigated gene expression of chemerin and chemerin receptors in 
various bovine tissues. The highest level of chemerin mRNA was observed in the 
liver of the Holstein/Friesian cattle, whereas lower expression was detected in other 
tissues including perirenal adipose tissue, adrenal gland, lung, spleen, and duodenum. 
Chemerin protein was detected in liver and plasma, indicating chemerin is a 
hepatokine secreted from liver in cattle. CMKLR1 was highly expressed in the lung, 
the liver, the adrenal gland, and the spleen; lower levels of expression were found in 
perirenal adipose tissue, longissimus muscle, rumen, and duodenum. CCRL2 was 
highly expressed in the lung, ileum, cecum, and rectal colon; lower levels of 
expression were also identified in the liver, perirenal adipose tissue, longissimus 
muscle, and duodenum. In contrast, GPR1 was predominantly expressed in the liver 
and forestomach (rumen, reticulum, and omasum). 
Next, the physiological effect of chemerin was examined by administration of a 
peptide analogue to sheep. The plasma insulin levels were sharply elevated after 
administration of 500 µg/head of the peptide analogue (Figure 1A). Consistently, 
plasma glucose and non-esterified fatty acid (NEFA) levels slightly declined after 
 administration (Figure 1B and 1C). Plasma triglyceride levels also increased rapidly 
after dministration but returned to the basal level within 30 min (Figure 1D). These 
data suggested that chemerin, as a hepatokine, regulated insulin secretion and 
consequently controlled plasma glucose and NEFA levels. 
To investigate the expressional changes in chemerin and its receptors mRNA 
levels during weaning period, they were measured in liver skeletal muscle and four 
depots of adipose tissue of pre-weaning (1.5 months of age) and post-weaning (3.5 
months of age) Japanese Black calves. The level of chemerin mRNA in mesenteric 
adipose tissue was higher in post-weaning calves. Interestingly, hepatic chemerin 
protein content was less abundant in post-weaning calves. However, there was no 
difference in plasma levels of chemerin between pre-weaning and post-weaning 
calves. Hepatic CCRL2 and GPR1 mRNA levels were higher in post-weaning calves 
Simultaneously, hepatic pyruvate carboxylase (PC) mRNA levels were lower in 
post-weaning calves, whereas hepatic phosphoenolpyruvate carboxykinase 2 (PCK2) 
increased. Meanwhile, the mRNA levels of the autophagy-related genes, atrogin 1 
and muscle-RING finger protein-1 (MuRF1), were not altered in post-weaning calves. 
Plasma insulin concentrations did not differ between the two groups of calves; 
however, plasma levels of some factors involved in hepatic metabolism were altered. 
Plasma levels of aspartate aminotransferase (AST), alanine transaminase (ALT), and 
lactate dehydrogenase (LDH), the major enzymes indicating hepatic condition, were 
significantly elevated in post-weaning calves. The plasma levels of phospholipids, 
which are secreted mainly from the liver as very low-density lipoproteins (VLDL) 
tended to decrease in post-weaning calves (P = 0.09). Acetoacetate, 
beta-hydroxybutyrate, and the levels of total ketone bodies significantly increased in 
 post-weaning calves. Takahashi et al suggested chemerin has inhibitory effect on 
expression of genes related to hepatic gluconeogenesis such as PCK and 
subsequently attenuates gluconeogenesis in liver (Takahashi et al., 2011). These 
results suggested that stress to the liver caused by abrupt weaning performed in this 
study might have affected the levels of hepatic chemerin protein. Decreased hepatic 
chemerin might upregulated PCK expression in liver of weaned calves. 
We further investigated the expressional changes in chemerin and chemerin 
receptors in growing Japanese Black cattle fed different diet (hay or concentrate). 
Chemerin mRNA levels in liver was higher in calves fed a concentrate diet than in 
those fed hay. The amount of chemerin protein in the liver was also higher in the 
concentrate-fed group. The levels of hepatic CMKLR1 mRNA gradually decreased as 
the calves grew up. Hepatic PC mRNA levels were lower in concentrate-fed calves at 
10 months of age. In contrast to expressional change in CMKLR1, hepatic PCK2 
expression elevated in 31 months of age in both group. These results indicated higher 
dietary energy intake is a factor for upregulation of hepatic chemerin expression in 
young weaned cattle, and chemerin signaling could be involved in hepatic 
gluconeogenesis in growing cattle. 
  
Chapter 4. Expression of chemerin and its receptors in lactating/ dry-off dairy cows 
and periparturient cows. 
Chemerin has been reported to exacerbate peripheral insulin sensitivity and to 
stimulate lipolysis in adipose tissue (Roh et al., 2007; Ernst et al., 2010). Previously, 
we reported that chemerin has a positive effect on lactogenesis in immortalized 
bovine mammary epithelial cells in vitro (Suzuki et al., 2015). Here, we investigated 
 the physiological role of chemerin in the metabolism of dairy cows. The level of 
hepatic chemerin mRNA was elevated in the dry period compared to the 
early/middle/late-lactation period, whereas CCRL2 remained at a high level at this 
period. Hepatic PC mRNA level decreased at middle and late-lactation period, 
although the expressional levels of PCK1 and PCK2 did not change during 
experiment period. Thus, chemerin signaling was not supposed to have a significant 
role in hepatic glucose metabolism through lactation period in cows. 
Focusing on peripartum period (-4 weeks to 4 weeks relative to parturition, in this 
study), hepatic chemerin mRNA expression slightly decreased at the day of 
parturition, and recovered thereafter. On the other hand, plasma chemerin level 
slightly decreased at partum day, but elevated in postpartum period. There were no 
differences in the expressional levels of CMKLR, CCRL2 and GPR1 in peripartum 
period. Plasma insulin level dramatically declined at the day of parturition and kept 
low levels in postpartum period. Because the pattern of plasma chemerin level in 
peripartum period was not consistent with the change inplasma insulin, it seemed that 
chemerin has minimal effect on the regulation of insulin secretion in this period. But, 
another physiological role of chemerin was suggested in postpartum period, such as 
lipolytic effect to provide NEFA from adipose tissue or inhibitory effect on insulin 
signaling during lactation. 
We also investigated the local function of chemerin within mammary gland 
because chemerin has chemoattractant ability which is essential for mammary gland 
immunity and involution. Expressions of the chemerin, CMKLR1, CCRL2 and GPR1 
mRNA were detected in the mammary grand as well as in the liver and adipose 
tissues of Holstein-Friesian dairy cows. Protein of chemerin, CMKLR1, and CCRL2 
 were localized in mammary epithelial cells and stroma cells, detected by IHC. We 
found that the mRNA expression of chemerin was elevated at the late-lactation 
period to the dry-off period in the mammary gland, compared to the 
early/middle-lactation period. CMKLR1 and CCRL2 expressions were elevated at the 
dry-off period. CD68 (Cluster of Differentiation 68) expression appeared to increase 
at the late-lactation and dry-off periods although this change was not significant (P = 
0.12). In cultured bovine mammary epithelial cells (MAC-T cells), the treatment with 
TNF-α, a potent proinflammatory cytokine, dramatically induced chemerin and 
CCRL2 expression. Considering the chemotactic property of chemerin to antigen 
presenting cells (Wittamer et al., 2003; Zabel et al., 2005), these results suggest that 
gene expression of chemerin began to increase from the late-lactation period and 
reached a peak at the dry-off period in order to facilitate the infiltration of immune 
cells into the mammary gland. Otherwise, the release of chemerin is supposed to be 
induced during inflammation in which proinflammatory cytokines are robustly 
released within mammary gland. These results together support the active role of 
chemerin in the maintenance of mammary gland function in mammary gland 
involution and immune response. 
  
 Conclusion 
 In summary, the present study provided following novel information about 
expressional regulation and physiological roles of the ANGPTL8 and chemerin as 
hepatokines in weaning calves, growing cattle and dairy cows; 
1. ANGPTL8 was highly expressed in the liver and secreted into blood in cattle. 
Hepatic ANGPTL8 expression was upregulated after weaning, whereas LPL 
expression in adipose tissue declined, indicating the role of ANGPTL8 to suppress 
lipid uptake into adipose tissue in postweaning period. In growing cattle, there 
was no difference in hepatic ANGPTL8 expression between cattle fed hay and 
those fed concentrate diet. However, its expression was elevated at 17 months of 
age when skeletal muscle develops most robustly in growing cattle. This result 
suggests elevated hepatic ANGPTL8 contributes to the development of skeletal 
muscle by inhibiting lipid accumulation in muscle. 
2. ANGPTL8 mRNA level in the liver was lower in early postpartum period in dairy 
cows. Simultaneously, plasma TG level was decreased, and plasma NEFA level 
was elevated. Plasma insulin level also decreased in postpartum period, which 
was suggested to be a regulator of hepatic ANGPTL8 in peripartum period. These 
results indicate that decreased ANGPTL8 expression might contribute to the 
decline in plasma triglycerides levels by facilitating triglyceride uptake by 
peripheral tissues. 
3. Chemerin was highly expressed in the liver and secreted into blood. CMKLR1 and 
CCRL2 were expressed in a variety of tissues, whereas GPR1 was expressed 
mainly in liver and forestomach. The administration of a chemerin analogue 
peptide sharply stimulated insulin secretion in sheep. 
 4. Hepatic chemerin protein level was downregulated after weaning without 
transcriptional regulation. Plasma levels of AST, ALT, and LDH were elevated in 
postweaning calves. Hepatic PCK2 expression was upregulated in the same calves. 
In growing cattle, chemerin expression in liver elevated in concentrate-fed cattle, 
compared to hay-fed cattle. Hepatic CMKLR1 expression gradually decreased and 
PCK2 expression elevated as cattle grew up. These results suggest that hepatic 
chemerin signaling was regulated by weaning, growth and dietary energy level to 
maintain glucose homeostasis in weaning calves and growing cattle. 
5. In dairy cows, hepatic chemerin expression was elevated in the dry-off period. 
During peripartum period, hepatic chemerin expression decreased at parturition. 
On the other hand, expression of the chemerin gene in the mammary gland was 
elevated from the late-lactation period to the dry-off period. CD68 expression was 
also increased in the dry off-period. These results shown chemerin has minimal 
effect on insulin signaling or glucose metabolism in peripartum dairy cows. 
However, chemerin was supposed to have regulatory role involution and immune 
response in mammary gland. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Plasma levels of insulin (A), glucose (B), NEFA (C) and TG (D) in cross-bred young 
sheep (n=6) weighing 23.4 ± 0.6 kg after administration of human chemerin analogue peptide 
(NH2-yFLPsQFa(Tic)S-COOH; 100 µg or 500 µg/head, saline as control). Insulin levels were 
measured by radio-immuno assay and metabolites levels were measured by enzymatic 
colorimetric assay. Levels are represented as mean ± SE and open symbols indicate significant 
differences from the average of pre-administration levels (P < 0.05, paired t-test). (Adapted from 
Suzuki Y et al., 2012) 
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